Summary
A major update to EU pharmaceutical laws to improve medicine access, safety, and environmental protection. 9 10.04.2024
Report
health
economy
science
environment
human rights
social policy
public administration
administrative reform
business and competition
information technology and data processing
Key points
- Modernization of the pharmaceutical legal framework to include advanced therapies like gene and cell therapy.
- Strengthening environmental protections by requiring assessments of how medicines impact water, soil, and ecosystems.
- Improving patient access to medicines, particularly for children and those with rare diseases through specific incentives.
- Combating antimicrobial resistance by regulating how antibiotics are prescribed and disposed of.
Vote
PPE (100)
S&D (69)
Renew (39)
PfE (32)
Verts/ALE (31)
ECR (28)
The Left (14)
NI (7)
ESN (4)
Total
228 In favor33 Against19 Abstained44 Absent
Vote
PPE
S&D
Renew
PfE
Verts/ALE
ECR
The Left
NI
ESN
Total
Speeches
32 Speeches in total
Pro
Contra
Henna VIRKKUNEN
PPE
Documents (PDFs)
Opinion on of the Committee on Legal Affairs on the Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC -
DRAFT OPINION on the proposal for a directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC
DRAFT REPORT on the proposal for a directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC
OPINION on the proposal for a directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC
REPORT on the proposal for a directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC
Union code relating to medicinal products for human use
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.